EUVIMEDEUVIMED entdecken
Crossref

2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors

Zheng Ma, Ge Cui, Lijie Dou, Fangfang Chen, Hexin Xie iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Zheng Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic C…. Hauptthemen laut MEDLINE: Boronic Acids, Klebsiella pneumoniae, Anti-Bacterial Agents, beta-Lactamase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NSFC-BRICS, Fundamental Research Funds for the Central Universities, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The expression of Klebsiella pneumoniae carbapenemase (KPC), a type of carbapenem‐hydrolyzing β‐lactamase, in Gram‐negative bacteria has caused significant bacterial resistance to carbapenems, the antibiotic of last resort. Herein, we describe the discovery of 2‐carboxyquinoline boronic acids as inhibitor of KPC. We have identified fluoro‐substituted carboxyquinoline boronic acids 1 e as the most potent inhibitor, with an IC 50 of 8.3 nM for KPC‐2, while this compound is significantly less efficient at reducing the activity of other β‐lactamases. This compound proved to have low cytotoxicity towards mammalian cells, as well as low haemolysis and antibacterial activity. However, 1 e potentiated the efficacy of β‐lactam antibiotics (e. g., meropenem and ceftazidime) against KPC‐2‐expressing resistant Klebsiella pneumonia by up to 256‐fold.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boronic AcidsKlebsiella pneumoniaeAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesQuinolinesBacterial ProteinsStructure-Activity RelationshipMicrobial Sensitivity TestsHumansMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

antibiotic resistancecarbapenemaseinhibitorβ-lactamase

Substanzen

Boronic AcidsAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesQuinolinesBacterial Proteinscarbapenemase

Autor:innen und Institutionen

  • State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techn…

ORCID-Profile: Hexin Xie

Förderung

  • NSFC-BRICS
  • Fundamental Research Funds for the Central Universities
  • Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism
  • Shanghai Municipal Education Commission
  • Research Program of State Key Laboratory of Bioreactor Engineering

Zitieren

APA

Ma, Z., Cui, G., Dou, L., Chen, F., & Xie, H. (2025). 2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202400901

Vancouver

Ma Z, Cui G, Dou L, Chen F, Xie H. 2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors. ChemMedChem. 2025. doi:10.1002/cmdc.202400901

BibTeX
@article{Ma2025,
  author = {Ma, Zheng and Cui, Ge and Dou, Lijie and Chen, Fangfang and Xie, Hexin},
  title = {2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400901}
}
Kostenlos starten →